Table 1.
Evaluation of marketed drugs.
| Index | Name | P-value | Odds Ratio | Combined Score |
|---|---|---|---|---|
| 1 | Calpain inhibitor I CTD 00002578 | 0.002548 | 624.41 | 3729.25 |
| 2 | Selenium (6+) CTD 00002696 | 0.002698 | 587.65 | 3476.15 |
| 3 | KU-55933 CTD 00004399 | 0.002847 | 554.97 | 3252.89 |
| 4 | Everolimus CTD 00003479 | 0.003596 | 434.22 | 2443.77 |
| 5 | S-1,2-Dichlorovinyl-N-acetylcysteine CTD 00002159 | 0.003596 | 434.22 | 2443.77 |
| 6 | Perhexiline CTD 00006493 | 0.003745 | 416.1 | 2324.86 |
| 7 | Niclosamide PC3 DOWN | 0.004344 | 356.59 | 1939.49 |
| 8 | Zimeldine PC3 DOWN | 0.004942 | 311.95 | 1656.47 |
| 9 | Alexidine PC3 DOWN | 0.005092 | 302.48 | 1597.17 |
| 10 | Luronit CTD 00006106 | 0.00539 | 285.17 | 1489.48 |